Predictability of Idiosyncratic Drug Toxicity Risk for Carboxylic Acid-Containing Drugs Based on the Chemical Stability of Acyl Glucuronide

Acyl glucuronides (AGs) formed from carboxylic acid-containing drugs have been considered to be a cause of idiosyncratic drug toxicity (IDT). Chemical stability of AGs is supposed to relate to their reactivity. In this study, the half-lives of 21 AGs of carboxylic drugs in potassium phosphate buffer (KPB), human serum albumin (HSA) solution, and human fresh plasma were analyzed in relation to the IDT risk derived from these drugs. The carboxylic drugs were classified into three safety categories of “safe,” “warning,” and “withdrawn” in terms of their IDT risk. As for the results, the half-lives of AGs in KPB correlated with the IDT risk better than those in HSA solution or in human fresh plasma with regard to the separation of the safe drugs from the warning drugs or the withdrawn drugs. In KPB, whereas the half-lives in the safe category were 7.2 h or longer, those in the withdrawn category were 1.7 h or shorter. The classification value of the half-life in KPB, which separated the safe drugs from the withdrawn drugs was calculated to be 3.6 h by regression analysis. In conclusion, this is the first report that clearly shows the relationship between the IDT risk and chemical stability of AGs in several in vitro systems. The KPB system was considered to be the best for evaluating the stability of AGs, and the classification value of the half-life in KPB serves as a useful key predictor for the IDT risk.

[1]  Masashi Yabuki,et al.  Evaluation of the Potential for Drug-Induced Liver Injury Based on in Vitro Covalent Binding to Human Liver Proteins , 2009, Drug Metabolism and Disposition.

[2]  Christian Skonberg,et al.  Metabolic activation of carboxylic acids. , 2008, Expert opinion on drug metabolism & toxicology.

[3]  J. Uetrecht,et al.  Immune-mediated adverse drug reactions. , 2009, Chemical research in toxicology.

[4]  T. Yoshioka,et al.  Structure-activity relationships for degradation reaction of 1-beta-o-acyl glucuronides: kinetic description and prediction of intrinsic electrophilic reactivity under physiological conditions. , 2009, Chemical research in toxicology.

[5]  J. Uetrecht,et al.  Prediction of a new drug's potential to cause idiosyncratic reactions. , 2001, Current opinion in drug discovery & development.

[6]  R. Boulieu,et al.  Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[7]  F. Azam,et al.  A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements. , 2004, Chemical research in toxicology.

[8]  M. Bailey,et al.  Limitations of hepatocytes and liver homogenates in modelling in vivo formation of acyl glucuronide-derived drug-protein adducts. , 1999, Journal of pharmacological and toxicological methods.

[9]  P C Smith,et al.  Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the rhesus monkey and in vitro with human serum albumin. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[10]  R. O. Oude Elferink,et al.  Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2). , 1998, Chemical research in toxicology.

[11]  Shufeng Zhou,et al.  Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring , 2007, Therapeutic drug monitoring.

[12]  Osamu Okazaki,et al.  A Zone Classification System for Risk Assessment of Idiosyncratic Drug Toxicity Using Daily Dose and Covalent Binding , 2009, Drug Metabolism and Disposition.

[13]  R. Dickinson,et al.  Studies on the reactivity of acyl glucuronides--II. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. , 1991, Biochemical pharmacology.

[14]  M. Bailey,et al.  Acyl glucuronide reactivity in perspective: biological consequences. , 2003, Chemico-biological interactions.

[15]  L. Benet,et al.  Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.

[16]  J. Uetrecht,et al.  New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. , 1999, Chemical research in toxicology.

[17]  L. Benet,et al.  Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[18]  B. Burchell,et al.  Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[19]  L. Benet,et al.  Irreversible binding of zomepirac to plasma protein in vitro and in vivo. , 1986, The Journal of clinical investigation.

[20]  U. Boelsterli.  Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions. , 2002, Current drug metabolism.

[21]  J. Magdalou,et al.  In vitro stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acids. , 2000, Chirality.

[22]  L. Benet,et al.  Predictability of the covalent binding of acidic drugs in man. , 1993, Life sciences.

[23]  B. Sallustio,et al.  Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[24]  T. Baillie,et al.  Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology. , 2006, Chemical research in toxicology.

[25]  J. Palmblad,et al.  Idiosyncratic drug‐induced agranulocytosis: Possible mechanisms and management , 2009, American journal of hematology.

[26]  A L Burlingame,et al.  Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies By tandem mass spectrometry. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[27]  S. Wolfe,et al.  Timing of new black box warnings and withdrawals for prescription medications. , 2002, JAMA.